The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Naltrexone Accelerates Full‐Thickness Cutaneous Wound Healing by Enhancing Remodeling
The FASEB Journal
01 April 2013
https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fasebj.27.1_supplement.754.3
Efficacy of Low Dose Naltrexone in Psoriasis
J Coll Physicians Surg Pak
June 2020
https://pubmed.ncbi.nlm.nih.gov/32703340/
Objective: To determine the efficacy of low dose naltrexone in the patients of psoriasis.
Study design: Non-randomised clinical trial.
Place and duration of study: Department of Dermatology, Jinnah Postgraduate Medical Centre, Karachi from January to July 2019.
Deanna Windham, DO - Psoriasis: A Novel Approach to Treatment (2017 Conference) (LDN, low dose naltrexone)
In this presentation, Dr Windham speaks about the patients in her practice and how her wealth of experience has helped her to be able to treat newer patients with greater efficacy. She also mentions the rapidly changing scientific outlook on Psoriasis, emphasising the importance of new research.
Deanna Windham, DO - Lupus: A Misunderstood Disease (2017 Conference) (LDN, low dose naltrexone)
Dr Deanna Windham currently works in the Whisker Wellness Institute in California, the United States. She and her institute first heard of Low Dose Naltrexone (LDN) around 12 years ago while establishing their adjunctive cancer treatment program.
Bev uses LDN for Graves, Psoriasis and Psoriatic Arthritis - 12th August (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.
Bev from Israel shares her Graves Disease and Psoriasis and Low Dose Naltrexone (LDN) story on the LDN Radio Show with Linda Elsegood.